RSV vaccines could offer protection against asthma

RSV vaccines could offer protection against asthma

Ghent, November 28, 2025 – Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy infection with respiratory syncytial virus (RSV) significantly increases the risk of developing childhood asthma—especially in children with a family history of allergy or asthma. Their study, published today in Science Immunology, suggests that protecting newborns against RSV could substantially reduce asthma cases later in life.

Latest stories

New immune process identified that may alleviate Alzheimer's disease

New immune process identified that may alleviate Alzheimer's disease

Belgian collaboration drives new momentum in amyloidosis care and research 

Belgian collaboration drives new momentum in amyloidosis care and research 

World Amyloidosis Day – 26 October | First benefit concert supports new Fund 

Psoriasis-linked gene mutation also impacts gut health 

Psoriasis-linked gene mutation also impacts gut health 

VIB researchers and colleagues uncover an unexpected role for psoriasis-associated gene CARD14 in intestinal function and disease. 

Belgian scientists discover how cells protect our skin from inflammatory disease – paving the way for new treatments

Belgian scientists discover how cells protect our skin from inflammatory disease – paving the way for new treatments

Researchers at VIB and Ghent University have uncovered a key mechanism that protects the skin from harmful inflammation

European scientists uncover new plant-based anti-inflammatory and anti-aging ingredients for sustainable cosmetics 

European scientists uncover new plant-based anti-inflammatory and anti-aging ingredients for sustainable cosmetics 

Confo Therapeutics – Unlocking the power of GPCRs

Confo Therapeutics – Unlocking the power of GPCRs

Same symptoms, different biology

Same symptoms, different biology

Researchers uncover new insights into diverging disease mechanisms in ALS

New insights into melanoma plasticity uncover a critical role of iron metabolism

New insights into melanoma plasticity uncover a critical role of iron metabolism

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-based Biotherapeutic Product Pipeline

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-based Biotherapeutic Product Pipeline

Spica Therapeutics Secures €1 Million VLAIO Grant to Advance Groundbreaking Macrophage-Targeted Cancer Therapy

Spica Therapeutics Secures €1 Million VLAIO Grant to Advance Groundbreaking Macrophage-Targeted Cancer Therapy

Scientists map dendritic cell reactions to vaccines 

Scientists map dendritic cell reactions to vaccines 

Ghent, 26 August 2025 – Belgian scientists have uncovered new details about how the immune system responds to vaccines. Dendritic cells, which are key immune messengers that help kick-start the body’s defenses, show specific responses to lipid nanoparticles. These findings, published in Cell Reports, could lead to safer and more effective vaccines.  

Contact us

VIB Press Office
VIB
Lies Vanneste
Lies Vanneste
Investor Relations Manager, VIB

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be